Venture Capital: Under-The -Radar Oncology Start-up Treeline Biosciences Nabs $261M

October 18, 2022 | Latest News, News, Venture Capital
https://dailyalts.com/wp-content/uploads/2022/10/Treeline-Founders.jpg

Treeline Biosciences has now raised a total of around $473 million in funding.

Treeline Biosciences, a cancer biotechnology startup led by biotech executives and Co-Founders Joshua Bilenker (CEO) and Jeffrey Engelman (CSO), has landed a Series A funding of $262 million to further its research pipeline. Bilenker, who had previously worked a stint in the oncology division of the FDA, went on to found a biotech company called Loxo Oncology which was later acquired by Eli Lilly (NYSE: LLY) for $8 billion in 2019. (BIO PHARMA DIVE)

The funding was led by KKR’s Health Care Strategic Growth Fund II, a fund dedicated to investing in high-growth health care-related companies. Other investors included Rock Springs Capital, ARCH Venture Partners, GV, OrbiMed, Access Industries, funds and accounts advised by T. Rowe Price Associates, Inc., Ajax Health/Zeus, Casdin Capital and Aisling Capital.

“While we’ve made significant progress in building the pipeline we envisioned at company formation, we are a team that wants our data to do the talking,” said the founders in an announcement on the firm’s website. “We are excited for the day when we provide scientific disclosure that has clear implications for patients with cancer and other serious diseases. That day is not today.”

The company, known to be very low-profile, said it had appointed around 130 people at its various locations, though it chooses not to reveal too much about its work.

Related Story: Nested Therapeutics Raises $90M Series ‘A’ Led By Goldman Sachs Asset Management

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Shape

Latest Alternative Investment News

https://dailyalts.com/wp-content/uploads/2023/02/the-eleventh-hour-gfac76b1a4_640.png
Alternative Investments/ESG: Six New Responsible Funds Flag Off Morgan Stanley’s ETF Platform

Morgan Stanley Investment Management (MSIM) has launched its ETF platform with six Calvert ETFs listed on NYSE Arca. The ETFs feature Calvert’s responsible investing approach and offer access to four…

https://dailyalts.com/wp-content/uploads/2023/02/adi-goldstein-i3gs_IIyvuI-unsplash.jpg
Artificial Intelligence: MusicLM, A New Generative AI Tool From Google, Creates Music From Text
February 2, 2023     Artificial Intelligence, News

Google (NASDAQ: GOOGL) recently published a research paper on its new AI tool, MusicLM, designed to create music. The tool is based on machine learning and is trained on vast…

https://dailyalts.com/wp-content/uploads/2023/02/augmented-reality-g86922a9f7_640.jpg
Artificial Intelligence: Snap Mulling AR Glasses Powered By Generative AI
February 2, 2023     Artificial Intelligence, News

Snap (NYSE: SNAP), the parent company of Snapchat, has hinted at future AR glasses powered by generative AI technology. CEO Evan Spiegel stated that AI will be critical to the…

https://dailyalts.com/wp-content/uploads/2023/02/94280bca-3fa2-430a-a5cd-2b2b997f622b.png
Digital Assets: Binance And Mastercard Launch Prepaid Crypto Card In Brazil
February 1, 2023     Digital Assets, News

Binance and Mastercard (NYSE: MA) have jointly launched the Binance Card in Brazil, allowing Binance users in the country to make purchases and pay bills with cryptocurrencies like bitcoin and…